SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-026514
Filing Date
2019-11-04
Accepted
2019-11-04 06:05:32
Documents
2
Period of Report
2019-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4837
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3563
  Complete submission text file 0000899243-19-026514.txt   9759
Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Dasu Badri N (Reporting) CIK: 0001310803 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 191188174

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations